ESC 2015 Schedule

Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.

Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom

Click on Date for Detailed Schedule

• Monday, August 31, 2015
• Tuesday, September 1, 2015

Monday, Mugust 31arch 16, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

• Interviewee:Dr. Vivek Reddy
• Topic:Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
• Embargo Lift: Sunday, August 30th at 5:38 PM

9:00 AM

OPEN TIME SLOT

9:30 AM

• Interviewee: Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
• Topic: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial AND Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
• Embargo Lift: Sunday, August 30th at 4:30 PM and Sunday, august 30th at 4:30 PM

10:00 AM

• Interviewee:Pr. Michel Ovize
• Topic:Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
• Embargo Lift: Sunday, August 30th, at 12:27 PM

10:30 AM (PENDING)

• Interviewee:Dr. Luigi Di Biase
• Topic:Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial
• Embargo Lift:Sunday August 30th, at 4:53 PM

11:00 AM

OPEN TIME SLOT

11:30 AM (PENDING)

• Interviewee:Dr. Morris Brown
• Topic:Principal results from Prevention And Treatment of Hypertension With Algorithm based therapY (PATHWAY): comparison of single and combination diuretics in essential hypertension - PATHWAY-3
• Embargo Lift:Monday August 31st at 5:16 PM

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

OPEN TIME SLOT

2:00 PM

OPEN TIME SLOT

2:30 PM

• Interviewee: Dr. Dirk Westermann
• Topic: Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm
• Embargo Lift: Sunday, August 30th at 11:00 AM

3:00 PM

• Interviewee:Dr. Basil Lewis
• Topic: ESC 2015 Wrap-up in Hebrew

3:30 PM

• Interviewee:Dr. Renato Lopes
• Topic: ESC 2015 Wrap-up in Portuguese

4:00 PM

• Interviewee:Pr. Freek Verheugt
• Topic: ESC 2015 Wrap-up from the Perspective of the Netherlands

4:30 PM

OPEN TIME SLOT

Tuesday, September 1, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

OPEN TIME SLOT

9:30 AM

• Interviewee: Takeshi Kimura
• Topic: ABSORB Japan: 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent
• Embrago Lift: Tuesday, September 1st at 5:06 PM

10:00 AM

• Interviewee: Gérard Helft
• Topic: The OPTIDUAL trial: 12 vs 48 months of clopidogrel after drug-eluting stent placement
• Embargo Lift: Monday, August 31st at 12:12 PM

10:30 AM

• Interviewee: Dr. Pamela Douglas
• Topic: Outcomes of an FFRCT diagnostic strategy versus usual care in suspected coronary artery disease: results from the PLATFORM (Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts) study
• Embargo Lift: Tuesday, September 1st at 4:30 PM

11:00 AM

• Interviewee: Dr. Hisao Ogawa
• Topic: A trial of Telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD) : the large biomarkers study with 1228 patients AND ESC 2015 Wrap-up in Japanese
• Embargo Lift: Monday August 31st at 4:30 PM

11:30 AM

OPEN TIME SLOT

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

• Interviewee: Dr. Gregg Stone
• Topic: Peri-infarct zone pacing to prevent adverse left ventricular remodeling in patients with very large myocardial infarction
• Embargo Lift: Sunday, August 30th at 11:54 AM

1:30 PM

• Interviewee: Dr. Patrick Serruys
• Topic: Everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents in patients with acute myocardial infarction. Results of the ABSORB STEMI TROFI II trial.
• Embargo Lift: Tuesday, September 1st at 4:48 PM

2:00 PM

• Interviewee: Dr. Gerasimos Filippatos
• Topic: Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
• Embargo Lift: Monday, August 31st at 11:18 AM

2:30 PM

OPEN TIME SLOT

3:00 PM

OPEN TIME SLOT

3:30 PM (PENDING)

• Interviewee: Dr. Carlos A. Morillo
• Topic: The BENznidazole Evaluation For Interrupting Trypanosomiasis trial
• Embargo Lift: Tuesday, September 1st at 12:08 PM

4:00 PM

• Interviewee: Dr. Dr. Stefan James (and guest Dr. Jonas Oldgren)
• Topic: Wrap-up from a Scandinavian Perspective

4:30 PM (PENDING)

• Interviewee: Gerasimos Filippatos
• Topic: Finerenone versus eplerenone in patients with worsening chronic heart failure with type 2 diabetes mellitus and/or chronic kidney disease: main results of the ARTS-HF trial
• Embrago Lift: Monday, August 31st at 11:18 AM

5:00 PM - 6:00 PM

• Interviewee: Pr. Gilles Montalescot
• Topic: Early aldosterone blockade in acute myocardial infarction: the randomized ALBATROSS Trial AND Assessment of an education and guidance program for apixaban adherence in non-valvular atrial fibrillation: the randomized AEGEAN study AND ESC 2015 Wrap-up in French
• Embargo Lift: Sunday, August 30th at 11:36 AM (ALBATROSS) and Sunday, August 30th at 5:16 PM (AEGEAN)